KEY FEATURES
| Full Name | Glucoprotein 130 |
|---|---|
| Synonym | IL6ST, CD130, CDW130, IL-6RB, IR6RB, Interleukin 6 signal transducer |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 125-8000pg/mL |
| Sensitivity | 75pg/mL |
| Sample Type | Serum, plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse gp130 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse gp130. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse gp130 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse gp130, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse gp130. You can calculate the concentration of Mouse gp130 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse gp130 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 425.57 | 1074.71 | 3008.16 | 412.8 | 993.53 | 2955.46 |
| Standard deviation | 27.32 | 60.08 | 159.13 | 21.34 | 53.45 | 155.75 |
| CV(%) | 6.42 | 5.59 | 5.29 | 5.17 | 5.38 | 5.27 |
RECOVERY
The recovery of Mouse gp130 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-110 | 101 |
| EDTA plasma (n=8) | 90-104 | 95 |
| Cell culture media (n=8) | 84-99 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse gp130 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with AES ELISA Kits
| TLE1 ELISA Kit | publications with AES and TLE1 |
| CTNNB1 ELISA Kit | publications with AES and CTNNB1 |
| CCND1 ELISA Kit | publications with AES and CCND1 |
| SIX3 ELISA Kit | publications with AES and SIX3 |
| MYC ELISA Kit | publications with AES and MYC |
| HDAC1 ELISA Kit | publications with AES and HDAC1 |
| LEF1 ELISA Kit | publications with AES and LEF1 |
| HNF1A ELISA Kit | publications with AES and HNF1A |
Pathways associated with AES ELISA Kit
| AMER1 Mutants Destabilize The Destruction Complex Pathway | AMER1 Mutants Destabilize The Destruction Complex Pathway |
| APC Truncation Mutants Are Not K63 Polyubiquitinated Pathway | APC Truncation Mutants Are Not K63 Polyubiquitinated Pathway |
| APC Truncation Mutants Have Impaired AXIN Binding Pathway | APC Truncation Mutants Have Impaired AXIN Binding Pathway |
| AXIN Missense Mutants Destabilize The Destruction Complex Pathway | AXIN Missense Mutants Destabilize The Destruction Complex Pathway |
| AXIN Mutants Destabilize The Destruction Complex, Activating WNT Signaling Pathway | AXIN Mutants Destabilize The Destruction Complex, Activating WNT Signaling Pathway |
| Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
| Degradation Of Beta-catenin By The Destruction Complex Pathway | Degradation Of Beta-catenin By The Destruction Complex Pathway |
| Disease Pathway | Disease Pathway |
| Presenilin Action In Notch And Wnt Signaling Pathway | Presenilin Action In Notch And Wnt Signaling Pathway |
| Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway | Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway |
Diseases associated with AES ELISA Kit
| Immune System Diseases | publications with AES and Immune System Diseases |
| Brain Diseases | publications with AES and Brain Diseases |
| Cardiovascular Diseases | publications with AES and Cardiovascular Diseases |
| Hypertension | publications with AES and Hypertension |
| Drug-Related Side Effects and Adverse Reactions | publications with AES and Drug-Related Side Effects and Adverse Reactions |
| Liver Diseases | publications with AES and Liver Diseases |
| Heart Diseases | publications with AES and Heart Diseases |
| Kidney Diseases | publications with AES and Kidney Diseases |
| Edema | publications with AES and Edema |
| Hepatitis | publications with AES and Hepatitis |
Organs/Tissues associated with AES ELISA Kit
| Blood | publications with AES and Blood |
| Liver | publications with AES and Liver |
| Skin | publications with AES and Skin |
| Lung | publications with AES and Lung |
| Bone | publications with AES and Bone |
| Heart | publications with AES and Heart |
| Brain | publications with AES and Brain |
| Kidney | publications with AES and Kidney |
| Vascular | publications with AES and Vascular |
| Muscle | publications with AES and Muscle |